Browsing Tag
Remibrutinib
2 posts
Novartis strengthens oral BTK franchise as Rhapsido expands beyond chronic spontaneous urticaria
Novartis expands Rhapsido into symptomatic dermographism as early sales grow and remibrutinib advances across MS and immune diseases.
Novartis’ remibrutinib shows promising results in Phase III studies for chronic spontaneous urticaria
Novartis has revealed encouraging data from the Phase III REMIX-1 and REMIX-2 studies. The studies focused on remibrutinib,…